Mirae Asset Global ETFs Holdings
GYRE icon

Mirae Asset Global ETFs Holdings’s Gyre Therapeutics GYRE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.1K Buy
5,617
+136
+2% +$1.06K ﹤0.01% 2959
2025
Q4 		$38.7K Buy
5,481
+1,278
+30% +$9.86K ﹤0.01% 2982
2025
Q3 		$31.4K Sell
4,203
-3,210
-43% -$24.4K ﹤0.01% 3015
2025
Q2 		$54.5K Buy
7,413
+3,244
+78% +$28.3K ﹤0.01% 2862
2025
Q1 		$32.2K Buy
4,169
+156
+4% +$1.71K ﹤0.01% 2917
2024
Q4 		$48.6K Buy
4,013
+152
+4% +$1.95K ﹤0.01% 2911
2024
Q3 		$48.4K Buy
+3,861
New +$49.8K ﹤0.01% 2919

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Mirae Asset Global ETFs Holdings's GYRE Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Gyre Therapeutics (GYRE) stake by 2.5% in Q1 2026, buying an estimated $1.06K and bringing the position to 5,617 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2959.

Mirae Asset Global ETFs Holdings first reported a position in GYRE in Q3 2024 and has held it in 7 quarters since. The position peaked at $54.5K in Q2 2025. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 5,617 shares of Gyre Therapeutics worth $39.1K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 136 Gyre Therapeutics shares in Q1 2026, an estimated $1.06K.
  • Gyre Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2959 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Gyre Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's Gyre Therapeutics position peaked at $54.5K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.